117 related articles for article (PubMed ID: 15866365)
1. Increased midkine levels in sera from patients with Alzheimer's disease.
Salama RH; Muramatsu H; Shimizu E; Hashimoto K; Ohgake S; Watanabe H; Komatsu N; Okamura N; Koike K; Shinoda N; Okada S; Iyo M; Muramatsu T
Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):611-6. PubMed ID: 15866365
[TBL] [Abstract][Full Text] [Related]
2. Serum midkine levels are increased in patients with various types of carcinomas.
Ikematsu S; Yano A; Aridome K; Kikuchi M; Kumai H; Nagano H; Okamoto K; Oda M; Sakuma S; Aikou T; Muramatsu H; Kadomatsu K; Muramatsu T
Br J Cancer; 2000 Sep; 83(6):701-6. PubMed ID: 10952771
[TBL] [Abstract][Full Text] [Related]
3. Low serum VEGF levels are associated with Alzheimer's disease.
Mateo I; Llorca J; Infante J; Rodríguez-Rodríguez E; Fernández-Viadero C; Peña N; Berciano J; Combarros O
Acta Neurol Scand; 2007 Jul; 116(1):56-8. PubMed ID: 17587256
[TBL] [Abstract][Full Text] [Related]
4. BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls.
Laske C; Stransky E; Leyhe T; Eschweiler GW; Maetzler W; Wittorf A; Soekadar S; Richartz E; Koehler N; Bartels M; Buchkremer G; Schott K
J Psychiatr Res; 2007 Aug; 41(5):387-94. PubMed ID: 16554070
[TBL] [Abstract][Full Text] [Related]
5. Elevated plasma levels of soluble CD40 in incipient Alzheimer's disease.
Buchhave P; Janciauskiene S; Zetterberg H; Blennow K; Minthon L; Hansson O
Neurosci Lett; 2009 Jan; 450(1):56-9. PubMed ID: 18996438
[TBL] [Abstract][Full Text] [Related]
6. [Serum levels of macrophage colony stimulating factor in the patients with Alzheimer's disease].
Kong QL; Zhang JM; Zhang ZX; Ge PJ; Xu YJ; Mi RS; Zhao YH; Sui YP; He W
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Jun; 24(3):298-301. PubMed ID: 12905639
[TBL] [Abstract][Full Text] [Related]
7. Increased acidic fibroblast growth factor concentrations in the serum and cerebrospinal fluid of patients with Alzheimer's disease.
Mashayekhi F; Hadavi M; Vaziri HR; Naji M
J Clin Neurosci; 2010 Mar; 17(3):357-9. PubMed ID: 20079650
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone secretagogue MK-677: no clinical effect on AD progression in a randomized trial.
Sevigny JJ; Ryan JM; van Dyck CH; Peng Y; Lines CR; Nessly ML;
Neurology; 2008 Nov; 71(21):1702-8. PubMed ID: 19015485
[TBL] [Abstract][Full Text] [Related]
9. [Plasma levels of endogenous hydrogen sulfide and homocysteine in patients with Alzheimer's disease and vascular dementia and the significance thereof].
Liu XQ; Liu XQ; Jiang P; Huang H; Yan Y
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2246-9. PubMed ID: 19087670
[TBL] [Abstract][Full Text] [Related]
10. Use of serum insulin-like growth factor-I levels to predict psychiatric non-response to donepezil in patients with Alzheimer's disease.
Tei E; Yamamoto H; Watanabe T; Miyazaki A; Nakadate T; Kato N; Mimura M
Growth Horm IGF Res; 2008 Feb; 18(1):47-54. PubMed ID: 17714966
[TBL] [Abstract][Full Text] [Related]
11. Increased midkine serum levels in pediatric embryonal tumor patients.
Lucas S; Reindl T; Henze G; Kurtz A; Sakuma S; Driever PH
J Pediatr Hematol Oncol; 2009 Oct; 31(10):713-7. PubMed ID: 19727009
[TBL] [Abstract][Full Text] [Related]
12. The influence of diagnosis, intra- and inter-person variability on serum and plasma Abeta levels.
Abdullah L; Paris D; Luis C; Quadros A; Parrish J; Valdes L; Keegan AP; Mathura V; Crawford F; Mullan M
Neurosci Lett; 2007 Nov; 428(2-3):53-8. PubMed ID: 17964720
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?
Ohrfelt A; Grognet P; Andreasen N; Wallin A; Vanmechelen E; Blennow K; Zetterberg H
Neurosci Lett; 2009 Feb; 450(3):332-5. PubMed ID: 19022350
[TBL] [Abstract][Full Text] [Related]
14. Association of platelet-derived soluble glycoprotein VI in plasma with Alzheimer's disease.
Laske C; Leyhe T; Stransky E; Eschweiler GW; Bueltmann A; Langer H; Stellos K; Gawaz M
J Psychiatr Res; 2008 Jul; 42(9):746-51. PubMed ID: 17854831
[TBL] [Abstract][Full Text] [Related]
15. Relationship between serum insulin-like growth factor-1 levels and Alzheimer's disease and vascular dementia.
Watanabe T; Miyazaki A; Katagiri T; Yamamoto H; Idei T; Iguchi T
J Am Geriatr Soc; 2005 Oct; 53(10):1748-53. PubMed ID: 16181175
[TBL] [Abstract][Full Text] [Related]
16. Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease.
Bermejo P; Martín-Aragón S; Benedí J; Susín C; Felici E; Gil P; Ribera JM; Villar AM
Immunol Lett; 2008 May; 117(2):198-202. PubMed ID: 18367253
[TBL] [Abstract][Full Text] [Related]
17. Correlation of elevated plasma levels of two structurally related growth factors, heparin affin regulatory peptide and midkine, in advanced solid tumor patients.
Soulié P; Héroult M; Bernard-Pierrot I; Caruelle D; Oglobine J; Barritault D; Courty J
Cancer Detect Prev; 2004; 28(5):319-24. PubMed ID: 15542254
[TBL] [Abstract][Full Text] [Related]
18. Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer's disease.
Kim TS; Lim HK; Lee JY; Kim DJ; Park S; Lee C; Lee CU
Neurosci Lett; 2008 May; 436(2):196-200. PubMed ID: 18378084
[TBL] [Abstract][Full Text] [Related]
19. Decreased plasma antioxidants in patients with Alzheimer's disease.
Kim TS; Pae CU; Yoon SJ; Jang WY; Lee NJ; Kim JJ; Lee SJ; Lee C; Paik IH; Lee CU
Int J Geriatr Psychiatry; 2006 Apr; 21(4):344-8. PubMed ID: 16534775
[TBL] [Abstract][Full Text] [Related]
20. A whole brain MR spectroscopy study from patients with Alzheimer's disease and mild cognitive impairment.
Falini A; Bozzali M; Magnani G; Pero G; Gambini A; Benedetti B; Mossini R; Franceschi M; Comi G; Scotti G; Filippi M
Neuroimage; 2005 Jul; 26(4):1159-63. PubMed ID: 15878675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]